209 related articles for article (PubMed ID: 15901925)
1. Sulforhodamine B assay and chemosensitivity.
Voigt W
Methods Mol Med; 2005; 110():39-48. PubMed ID: 15901925
[TBL] [Abstract][Full Text] [Related]
2. New colorimetric cytotoxicity assay for anticancer-drug screening.
Skehan P; Storeng R; Scudiero D; Monks A; McMahon J; Vistica D; Warren JT; Bokesch H; Kenney S; Boyd MR
J Natl Cancer Inst; 1990 Jul; 82(13):1107-12. PubMed ID: 2359136
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of cell proliferation and cell death based assays in chemosensitivity testing.
Gerçel-Taylor C; Ackermann MA; Taylor DD
Anticancer Res; 2001; 21(4A):2761-8. PubMed ID: 11724352
[TBL] [Abstract][Full Text] [Related]
4. In vitro assays of chemotherapeutic sensitivity.
Carney DN; Winkler CF
Important Adv Oncol; 1985; ():78-103. PubMed ID: 3916747
[TBL] [Abstract][Full Text] [Related]
5. Assay of anticancer drugs in tissue culture: comparison of a tetrazolium-based assay and a protein binding dye assay in short-term cultures derived from human malignant glioma.
Haselsberger K; Peterson DC; Thomas DG; Darling JL
Anticancer Drugs; 1996 May; 7(3):331-8. PubMed ID: 8792008
[TBL] [Abstract][Full Text] [Related]
6. A sensitive assay for the evaluation of cytotoxicity and its pharmacologic modulation in human solid tumor-derived cell lines exposed to cancer-therapeutic agents.
Mirzayans R; Andrais B; Scott A; Tessier A; Murray D
J Pharm Pharm Sci; 2007; 10(2):298s-311s. PubMed ID: 17718933
[TBL] [Abstract][Full Text] [Related]
7. The sulphorhodamine (SRB) assay and other approaches to testing plant extracts and derived compounds for activities related to reputed anticancer activity.
Houghton P; Fang R; Techatanawat I; Steventon G; Hylands PJ; Lee CC
Methods; 2007 Aug; 42(4):377-87. PubMed ID: 17560325
[TBL] [Abstract][Full Text] [Related]
8. A comparison of clonogenic, microtetrazolium and sulforhodamine B assays for determination of cisplatin cytotoxicity in human ovarian carcinoma cell lines.
Perez RP; Godwin AK; Handel LM; Hamilton TC
Eur J Cancer; 1993; 29A(3):395-9. PubMed ID: 8398340
[TBL] [Abstract][Full Text] [Related]
9. Colorimetric chemosensitivity testing using sulforhodamine B.
Kubota T; Takahara T; Nagata M; Furukawa T; Kase S; Tanino H; Ishibiki K; Kitajima M
J Surg Oncol; 1993 Feb; 52(2):83-8. PubMed ID: 8468977
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing.
Keepers YP; Pizao PE; Peters GJ; van Ark-Otte J; Winograd B; Pinedo HM
Eur J Cancer; 1991; 27(7):897-900. PubMed ID: 1834124
[TBL] [Abstract][Full Text] [Related]
11. The ChemoFx assay: an ex vivo cell culture assay for predicting anticancer drug responses.
Ochs RL; Burholt D; Kornblith P
Methods Mol Med; 2005; 110():155-72. PubMed ID: 15901934
[TBL] [Abstract][Full Text] [Related]
12. [Predictive value of in vitro MTT assay chemosensitivity test of cytotoxic drug activity in cervical cancer].
Xiao Y; Li JD; Shi HL; Liu JH; Feng YL; Li MD
Ai Zheng; 2007 Apr; 26(4):386-9. PubMed ID: 17430657
[TBL] [Abstract][Full Text] [Related]
13. Comparison of two colorimetric assays as cytotoxicity endpoints for an in vitro screen for antitumour agents.
Fricker SP; Buckley RG
Anticancer Res; 1996; 16(6B):3755-60. PubMed ID: 9042253
[TBL] [Abstract][Full Text] [Related]
14. Key considerations when using the sulforhodamine B assay for screening novel anticancer agents.
Shakil MS; Rana Z; Hanif M; Rosengren RJ
Anticancer Drugs; 2022 Jan; 33(1):6-10. PubMed ID: 34261912
[TBL] [Abstract][Full Text] [Related]
15. An overview of chemosensitivity testing.
Blumenthal RD
Methods Mol Med; 2005; 110():3-18. PubMed ID: 15901922
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin fails to interfere with the antiproliferative and cytotoxic effects of antitumor drugs.
Gewirtz DA; Di X; Walker TD; Sawyer ST
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2232-8. PubMed ID: 16609039
[TBL] [Abstract][Full Text] [Related]
17. Spectrophotometric determination of clonogenic capacity of leukemic cells in a semisolid microtiter culture system.
Schweitzer CM; van de Loosdrecht AA; Jonkhoff AR; Ossenkoppele GJ; Huijgens PC; Dräger AM; Broekhoven MG; Langenhuijsen MM
Exp Hematol; 1993 Apr; 21(4):573-8. PubMed ID: 8462666
[TBL] [Abstract][Full Text] [Related]
18. Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines.
Rubinstein LV; Shoemaker RH; Paull KD; Simon RM; Tosini S; Skehan P; Scudiero DA; Monks A; Boyd MR
J Natl Cancer Inst; 1990 Jul; 82(13):1113-8. PubMed ID: 2359137
[TBL] [Abstract][Full Text] [Related]
19. Fluorescently labeled liposomes for monitoring cholera toxin binding to epithelial cells.
Edwards KA; Duan F; Baeumner AJ; March JC
Anal Biochem; 2008 Sep; 380(1):59-67. PubMed ID: 18549803
[TBL] [Abstract][Full Text] [Related]
20. Effect of culture conditions on the chemosensitivity of ovarian cancer cell lines.
Fernando A; Glaysher S; Conroy M; Pekalski M; Smith J; Knight LA; Di Nicolantonio F; Cree IA
Anticancer Drugs; 2006 Sep; 17(8):913-9. PubMed ID: 16940801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
